Showing results (791-800 of 833) with videos related to

Sort By:
Pageof 84
Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2024
Possible scenarios for the spread of mpox outside the endemic focus in AfricaEskild Petersen, Ulrik Hvid, Oyewale Tomori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort studyPeter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Critical Care Medicine|May 17, 2011
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trialJens U Jensen, Lars Hein, Bettina Lundgren, et al.
Medicine|July 20, 2018
Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial resultsNeval Ete Wareham, Caspar Da Cunha-Bang, Álvaro H Borges, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Critical Care Medicine|December 11, 2014
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroximeJens-Ulrik S Jensen, Lars Hein, Bettina Lundgren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
Pageof 84